Updated:
Institutional investors shifted their U.S. equity exposure in different directions during the second quarter, with large-cap managers increasing technology holdings after a strong sector rally while hedge funds remained heavily overweight small-cap healthcare and many filers reduced energy positions. The picture, based on portfolios as of June 30, comes from quarterly Form 13F disclosures and does not show what managers have traded since then.
The filings suggest a market without a single, unified institutional bet. Morgan Stanley’s analysis of the disclosures found significant technology additions among large-cap investors, but Reuters’ review of 6,371 filings found that investors were nearly split on the largest technology companies. Small-cap hedge funds’ pronounced healthcare exposure and net selling across major energy names added to the evidence of sector-by-sector rotation rather than broad consensus.
Technology gains were accompanied by divided positioning
Morgan Stanley reported that large-cap investors increased technology exposure by 5.8% in active-share terms in Q2, after the sector gained 32% during the quarter. Active share measures how a portfolio differs from its benchmark; the reported increase indicates a larger relative allocation to technology, not a uniform purchase of every technology stock. Hedge funds also increased their technology exposure, by 3.9%, according to the bank’s analysis.
Yet the broader filings do not indicate that investors all crowded into the same mega-cap names. Reuters reported that about 44% of the 6,371 managers in its sample reduced holdings in the so-called Magnificent Seven, while 42% increased them. The near split highlights how an aggregate sector allocation can rise even as many individual funds trim particular large companies.
Semiconductors were a comparatively stronger point of agreement in the source analysis: 48% of filers were net buyers of the group, against 34.5% who were net sellers. These percentages describe the balance of reporting managers, not the dollar value of all purchases and sales, and they do not establish that buying continued after the quarter ended.
Small-cap hedge funds favored healthcare
The positioning differed in smaller companies. Morgan Stanley’s figures put healthcare at 39% of small-cap hedge-fund assets, compared with a 22% weight in the Russell 2000 index. The bank attributed much of the overweight to biotech positions, making healthcare the clearest relative preference highlighted in its small-cap analysis.
At the same time, hedge funds cut small-cap industrials by 4.9%, according to the report. Across the broader small-cap filer group, Morgan Stanley identified healthcare and financials as areas of increased exposure and industrials as an area of reduced exposure. The contrast with large-cap technology buying underlines that institutional positioning varied by company size and sector rather than following one simple market-wide rotation.
Energy shares saw more net sellers than buyers
Energy was another area of retreat in the filings. Despite a rise in crude prices during Q2, 40.3% of filers were net sellers of major energy names, while 28% were net buyers, according to the Investing.com summary of the data. The figures count managers by direction of reported position changes; they do not measure the total amount of capital withdrawn from energy.
Morgan Stanley’s analysis separately found that large-cap investors reduced energy exposure by 1.3% in active-share terms and financials by 0.9%. This provides a benchmark-relative view that complements, but is not identical to, the count of managers who bought or sold individual energy stocks. Neither measure alone explains investors’ motivations.
Stock-level changes ranged beyond the largest technology firms
Morgan Stanley’s screen of the largest increases in active share within the S&P 500 included AES, Fox, EchoStar, Electronic Arts and Super Micro Computer among the leading names. The Trade Desk, Intuit, Warner Bros. Discovery and Wynn Resorts also appeared on the list. These are relative portfolio-allocation changes identified by the bank’s screen; they should not be read as proof that every institution increased its position in those companies.
The varied list reinforces the limits of treating “institutional buying” as one trade. A manager can raise a stock’s weight relative to a benchmark while another sells it, and position values can also change because of share-price movements. The filings record holdings at a quarter-end snapshot, not a continuous transaction history.
Berkshire’s filing shows concentration, not its entire balance sheet
Berkshire Hathaway’s reported 13F portfolio was valued at about $299.3 billion as of June 30. Apple represented 22.0% of that disclosed portfolio, followed by American Express at 17.1%, Coca-Cola at 10.9%, Alphabet at 9.4% and Bank of America at 9.2%. Chevron and Occidental Petroleum accounted for 4.7% and 4.3%, respectively.
Those percentages refer to Berkshire’s reported 13F holdings, not the conglomerate’s total assets or all of its investments. The filing offers a useful snapshot of reportable securities, but it is not a complete view of a manager’s finances or a real-time statement of its investment decisions.
Why the filings arrive late—and what they cannot show
Under the SEC’s Form 13F reporting rule, covered institutional investment managers must file within 45 days after the end of each calendar quarter. The Q2 filings therefore reflected positions at June 30 and were due in mid-August, leaving a gap between the portfolio date and public disclosure.
That delay matters when using filings to interpret current market sentiment: trades made after June 30 are absent from the snapshot. The disclosures can help document how managers’ reported holdings changed from one quarter to another, but the Q2 data cannot establish what funds owned on October 6 or whether the same sector preferences remain in place. The next quarterly round will provide a later snapshot, not a daily update.
